Global Tavaborole Market Growth 2025-2031

December 2025 | 79 pages | ID: GEB41559AF5EN
LP Information

Abstracts

The global Tavaborole market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

It is a topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed.

United States market for Tavaborole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Tavaborole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Tavaborole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Tavaborole players cover VIRUJ Pharmaceutical, Wavelength, Biophore, Glenmark Life Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Tavaborole Industry Forecast” looks at past sales and reviews total world Tavaborole sales in 2024, providing a comprehensive analysis by region and market sector of projected Tavaborole sales for 2025 through 2031. With Tavaborole sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tavaborole industry.

This Insight Report provides a comprehensive analysis of the global Tavaborole landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tavaborole portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tavaborole market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tavaborole and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tavaborole.

This report presents a comprehensive overview, market shares, and growth opportunities of Tavaborole market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Purity Above 98%
• Purity Below 98%

Segmentation by Application:

• Onychomycosis
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• VIRUJ Pharmaceutical
• Wavelength
• Biophore
• Glenmark Life Sciences

Key Questions Addressed in this Report

What is the 10-year outlook for the global Tavaborole market?

What factors are driving Tavaborole market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Tavaborole market opportunities vary by end market size?

How does Tavaborole break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Tavaborole Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Tavaborole by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Tavaborole by Country/Region, 2020, 2024 & 2031
2.2 Tavaborole Segment by Type
  2.2.1 Purity Above 98%
  2.2.2 Purity Below 98%
2.3 Tavaborole Sales by Type
  2.3.1 Global Tavaborole Sales Market Share by Type (2020-2025)
  2.3.2 Global Tavaborole Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Tavaborole Sale Price by Type (2020-2025)
2.4 Tavaborole Segment by Application
  2.4.1 Onychomycosis
  2.4.2 Other
2.5 Tavaborole Sales by Application
  2.5.1 Global Tavaborole Sale Market Share by Application (2020-2025)
  2.5.2 Global Tavaborole Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Tavaborole Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Tavaborole Breakdown Data by Company
  3.1.1 Global Tavaborole Annual Sales by Company (2020-2025)
  3.1.2 Global Tavaborole Sales Market Share by Company (2020-2025)
3.2 Global Tavaborole Annual Revenue by Company (2020-2025)
  3.2.1 Global Tavaborole Revenue by Company (2020-2025)
  3.2.2 Global Tavaborole Revenue Market Share by Company (2020-2025)
3.3 Global Tavaborole Sale Price by Company
3.4 Key Manufacturers Tavaborole Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Tavaborole Product Location Distribution
  3.4.2 Players Tavaborole Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR TAVABOROLE BY GEOGRAPHIC REGION

4.1 World Historic Tavaborole Market Size by Geographic Region (2020-2025)
  4.1.1 Global Tavaborole Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Tavaborole Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Tavaborole Market Size by Country/Region (2020-2025)
  4.2.1 Global Tavaborole Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Tavaborole Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tavaborole Sales Growth
4.4 APAC Tavaborole Sales Growth
4.5 Europe Tavaborole Sales Growth
4.6 Middle East & Africa Tavaborole Sales Growth

5 AMERICAS

5.1 Americas Tavaborole Sales by Country
  5.1.1 Americas Tavaborole Sales by Country (2020-2025)
  5.1.2 Americas Tavaborole Revenue by Country (2020-2025)
5.2 Americas Tavaborole Sales by Type (2020-2025)
5.3 Americas Tavaborole Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Tavaborole Sales by Region
  6.1.1 APAC Tavaborole Sales by Region (2020-2025)
  6.1.2 APAC Tavaborole Revenue by Region (2020-2025)
6.2 APAC Tavaborole Sales by Type (2020-2025)
6.3 APAC Tavaborole Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Tavaborole by Country
  7.1.1 Europe Tavaborole Sales by Country (2020-2025)
  7.1.2 Europe Tavaborole Revenue by Country (2020-2025)
7.2 Europe Tavaborole Sales by Type (2020-2025)
7.3 Europe Tavaborole Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Tavaborole by Country
  8.1.1 Middle East & Africa Tavaborole Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Tavaborole Revenue by Country (2020-2025)
8.2 Middle East & Africa Tavaborole Sales by Type (2020-2025)
8.3 Middle East & Africa Tavaborole Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tavaborole
10.3 Manufacturing Process Analysis of Tavaborole
10.4 Industry Chain Structure of Tavaborole

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Tavaborole Distributors
11.3 Tavaborole Customer

12 WORLD FORECAST REVIEW FOR TAVABOROLE BY GEOGRAPHIC REGION

12.1 Global Tavaborole Market Size Forecast by Region
  12.1.1 Global Tavaborole Forecast by Region (2026-2031)
  12.1.2 Global Tavaborole Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Tavaborole Forecast by Type (2026-2031)
12.7 Global Tavaborole Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 VIRUJ Pharmaceutical
  13.1.1 VIRUJ Pharmaceutical Company Information
  13.1.2 VIRUJ Pharmaceutical Tavaborole Product Portfolios and Specifications
  13.1.3 VIRUJ Pharmaceutical Tavaborole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 VIRUJ Pharmaceutical Main Business Overview
  13.1.5 VIRUJ Pharmaceutical Latest Developments
13.2 Wavelength
  13.2.1 Wavelength Company Information
  13.2.2 Wavelength Tavaborole Product Portfolios and Specifications
  13.2.3 Wavelength Tavaborole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Wavelength Main Business Overview
  13.2.5 Wavelength Latest Developments
13.3 Biophore
  13.3.1 Biophore Company Information
  13.3.2 Biophore Tavaborole Product Portfolios and Specifications
  13.3.3 Biophore Tavaborole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Biophore Main Business Overview
  13.3.5 Biophore Latest Developments
13.4 Glenmark Life Sciences
  13.4.1 Glenmark Life Sciences Company Information
  13.4.2 Glenmark Life Sciences Tavaborole Product Portfolios and Specifications
  13.4.3 Glenmark Life Sciences Tavaborole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Glenmark Life Sciences Main Business Overview
  13.4.5 Glenmark Life Sciences Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Tavaborole Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Tavaborole Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Purity Above 98%
Table 4. Major Players of Purity Below 98%
Table 5. Global Tavaborole Sales by Type (2020-2025) & (MT)
Table 6. Global Tavaborole Sales Market Share by Type (2020-2025)
Table 7. Global Tavaborole Revenue by Type (2020-2025) & ($ million)
Table 8. Global Tavaborole Revenue Market Share by Type (2020-2025)
Table 9. Global Tavaborole Sale Price by Type (2020-2025) & (USD/Kg)
Table 10. Global Tavaborole Sale by Application (2020-2025) & (MT)
Table 11. Global Tavaborole Sale Market Share by Application (2020-2025)
Table 12. Global Tavaborole Revenue by Application (2020-2025) & ($ million)
Table 13. Global Tavaborole Revenue Market Share by Application (2020-2025)
Table 14. Global Tavaborole Sale Price by Application (2020-2025) & (USD/Kg)
Table 15. Global Tavaborole Sales by Company (2020-2025) & (MT)
Table 16. Global Tavaborole Sales Market Share by Company (2020-2025)
Table 17. Global Tavaborole Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Tavaborole Revenue Market Share by Company (2020-2025)
Table 19. Global Tavaborole Sale Price by Company (2020-2025) & (USD/Kg)
Table 20. Key Manufacturers Tavaborole Producing Area Distribution and Sales Area
Table 21. Players Tavaborole Products Offered
Table 22. Tavaborole Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Tavaborole Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Tavaborole Sales Market Share Geographic Region (2020-2025)
Table 27. Global Tavaborole Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Tavaborole Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Tavaborole Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Tavaborole Sales Market Share by Country/Region (2020-2025)
Table 31. Global Tavaborole Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Tavaborole Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Tavaborole Sales by Country (2020-2025) & (MT)
Table 34. Americas Tavaborole Sales Market Share by Country (2020-2025)
Table 35. Americas Tavaborole Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Tavaborole Sales by Type (2020-2025) & (MT)
Table 37. Americas Tavaborole Sales by Application (2020-2025) & (MT)
Table 38. APAC Tavaborole Sales by Region (2020-2025) & (MT)
Table 39. APAC Tavaborole Sales Market Share by Region (2020-2025)
Table 40. APAC Tavaborole Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Tavaborole Sales by Type (2020-2025) & (MT)
Table 42. APAC Tavaborole Sales by Application (2020-2025) & (MT)
Table 43. Europe Tavaborole Sales by Country (2020-2025) & (MT)
Table 44. Europe Tavaborole Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Tavaborole Sales by Type (2020-2025) & (MT)
Table 46. Europe Tavaborole Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Tavaborole Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Tavaborole Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Tavaborole Sales by Type (2020-2025) & (MT)
Table 50. Middle East & Africa Tavaborole Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Tavaborole
Table 52. Key Market Challenges & Risks of Tavaborole
Table 53. Key Industry Trends of Tavaborole
Table 54. Tavaborole Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Tavaborole Distributors List
Table 57. Tavaborole Customer List
Table 58. Global Tavaborole Sales Forecast by Region (2026-2031) & (MT)
Table 59. Global Tavaborole Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Tavaborole Sales Forecast by Country (2026-2031) & (MT)
Table 61. Americas Tavaborole Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Tavaborole Sales Forecast by Region (2026-2031) & (MT)
Table 63. APAC Tavaborole Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Tavaborole Sales Forecast by Country (2026-2031) & (MT)
Table 65. Europe Tavaborole Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Tavaborole Sales Forecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Tavaborole Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Tavaborole Sales Forecast by Type (2026-2031) & (MT)
Table 69. Global Tavaborole Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Tavaborole Sales Forecast by Application (2026-2031) & (MT)
Table 71. Global Tavaborole Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. VIRUJ Pharmaceutical Basic Information, Tavaborole Manufacturing Base, Sales Area and Its Competitors
Table 73. VIRUJ Pharmaceutical Tavaborole Product Portfolios and Specifications
Table 74. VIRUJ Pharmaceutical Tavaborole Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. VIRUJ Pharmaceutical Main Business
Table 76. VIRUJ Pharmaceutical Latest Developments
Table 77. Wavelength Basic Information, Tavaborole Manufacturing Base, Sales Area and Its Competitors
Table 78. Wavelength Tavaborole Product Portfolios and Specifications
Table 79. Wavelength Tavaborole Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. Wavelength Main Business
Table 81. Wavelength Latest Developments
Table 82. Biophore Basic Information, Tavaborole Manufacturing Base, Sales Area and Its Competitors
Table 83. Biophore Tavaborole Product Portfolios and Specifications
Table 84. Biophore Tavaborole Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 85. Biophore Main Business
Table 86. Biophore Latest Developments
Table 87. Glenmark Life Sciences Basic Information, Tavaborole Manufacturing Base, Sales Area and Its Competitors
Table 88. Glenmark Life Sciences Tavaborole Product Portfolios and Specifications
Table 89. Glenmark Life Sciences Tavaborole Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. Glenmark Life Sciences Main Business
Table 91. Glenmark Life Sciences Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Tavaborole
Figure 2. Tavaborole Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tavaborole Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Tavaborole Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Tavaborole Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Tavaborole Sales Market Share by Country/Region (2024)
Figure 10. Tavaborole Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Purity Above 98%
Figure 12. Product Picture of Purity Below 98%
Figure 13. Global Tavaborole Sales Market Share by Type in 2025
Figure 14. Global Tavaborole Revenue Market Share by Type (2020-2025)
Figure 15. Tavaborole Consumed in Onychomycosis
Figure 16. Global Tavaborole Market: Onychomycosis (2020-2025) & (MT)
Figure 17. Tavaborole Consumed in Other
Figure 18. Global Tavaborole Market: Other (2020-2025) & (MT)
Figure 19. Global Tavaborole Sale Market Share by Application (2024)
Figure 20. Global Tavaborole Revenue Market Share by Application in 2025
Figure 21. Tavaborole Sales by Company in 2025 (MT)
Figure 22. Global Tavaborole Sales Market Share by Company in 2025
Figure 23. Tavaborole Revenue by Company in 2025 ($ millions)
Figure 24. Global Tavaborole Revenue Market Share by Company in 2025
Figure 25. Global Tavaborole Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Tavaborole Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Tavaborole Sales 2020-2025 (MT)
Figure 28. Americas Tavaborole Revenue 2020-2025 ($ millions)
Figure 29. APAC Tavaborole Sales 2020-2025 (MT)
Figure 30. APAC Tavaborole Revenue 2020-2025 ($ millions)
Figure 31. Europe Tavaborole Sales 2020-2025 (MT)
Figure 32. Europe Tavaborole Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Tavaborole Sales 2020-2025 (MT)
Figure 34. Middle East & Africa Tavaborole Revenue 2020-2025 ($ millions)
Figure 35. Americas Tavaborole Sales Market Share by Country in 2025
Figure 36. Americas Tavaborole Revenue Market Share by Country (2020-2025)
Figure 37. Americas Tavaborole Sales Market Share by Type (2020-2025)
Figure 38. Americas Tavaborole Sales Market Share by Application (2020-2025)
Figure 39. United States Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Tavaborole Sales Market Share by Region in 2025
Figure 44. APAC Tavaborole Revenue Market Share by Region (2020-2025)
Figure 45. APAC Tavaborole Sales Market Share by Type (2020-2025)
Figure 46. APAC Tavaborole Sales Market Share by Application (2020-2025)
Figure 47. China Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 51. India Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Tavaborole Sales Market Share by Country in 2025
Figure 55. Europe Tavaborole Revenue Market Share by Country (2020-2025)
Figure 56. Europe Tavaborole Sales Market Share by Type (2020-2025)
Figure 57. Europe Tavaborole Sales Market Share by Application (2020-2025)
Figure 58. Germany Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 59. France Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Tavaborole Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Tavaborole Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Tavaborole Sales Market Share by Application (2020-2025)
Figure 66. Egypt Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Tavaborole Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Tavaborole in 2025
Figure 72. Manufacturing Process Analysis of Tavaborole
Figure 73. Industry Chain Structure of Tavaborole
Figure 74. Channels of Distribution
Figure 75. Global Tavaborole Sales Market Forecast by Region (2026-2031)
Figure 76. Global Tavaborole Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Tavaborole Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Tavaborole Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Tavaborole Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Tavaborole Revenue Market Share Forecast by Application (2026-2031)